Market Overview:
The global regenerative medicine for cartilage market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of joint diseases, rising awareness about regenerative therapies, and technological advancements in the field of regenerative medicine. The cell-based segment is expected to dominate the global regenerative medicine for cartilage market during the forecast period. This can be attributed to the advantages offered by cell-based therapies over non-cell-based therapies, such as higher efficacy and fewer side effects. The hyaline cartilage repair and regeneration segment is expected to account for a major share of this market during the forecast period owing to its high demand across various applications. Geographically, North America is estimated to hold a major share of the global regenerative medicine for cartilage market in 2018. This can be attributedto factors such asthe presenceof advanced healthcare infrastructure,high prevalenceof joint diseases,and increasing adoptionof novel technologiesin this region.
Product Definition:
Regenerative medicine is the process of repairing, regenerating, or replacing tissue or organ function lost due to damage or disease. Cartilage is a type of connective tissue that helps form joints in the body. Regenerative medicine can help treat cartilage damage and restore joint function.
Cell-based:
Cell-based therapies are regenerative medicines that are based on the principle that all human cells have the potential to regenerate and repair damaged tissues. The market is in its nascent stage; however, it has a high growth potential as many companies are investing heavily in this area. Cell-based therapy for cartilage defects has been around for more than two decades and yet there is still much work to be done before this can be considered a mainstream treatment option.
Non-cell-based:
Non-cell-based therapies are used in the field of regenerative medicine for cartilage regeneration. These therapies include extracellular matrix proteins, growth factors, and cytokines. Extracellular matrix proteins can be extracted from the cartilages or tendons of animals or humans.
Application Insights:
The hyaline cartilage repair and regeneration segment dominated the global regenerative medicine for cartilage market in 2017. This can be attributed to increasing incidence of sports-related injuries and trauma cases that require surgical intervention. For instance, according to the CDC, around 647,000 people sustained a non-fatal injury in U.S. In addition, as per the National Health Statistics Report 2016 data published by CDC; around 1 out of every 3 adults aged 65 years or above were hospitalized due to fall injuries in 2015.
In terms of revenue, elastic tissue repair and regeneration is expected to witness lucrative growth over the forecast period owing to its high demand from various applications including total knee arthroplasty (TKA), total hip replacement (THR), shoulder replacement surgery as well as dental implants surgery among others at a global level.
Regional Analysis:
North America held the largest revenue share in 2017 owing to the presence of a large number of global players and increased funding for R&D. The region is expected to maintain its dominance throughout the forecast period due to increasing incidence of osteoporosis, which can be treated with regenerative medicine. In addition, growing prevalence of sports injuries and rising awareness about Cartilage Repair Products (CPR) are also contributing towards regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in healthcare expenditure by governments as well as private organizations coupled with rising awareness among people regarding regenerative medicines for cartilage repair & regeneration applications. Moreover, supportive government initiatives such as “Make in India†initiative by Indian government that encourages domestic manufacturing are expected drive regional demand during the forecast period.
Growth Factors:
- Increasing prevalence of arthritis and other cartilage-related diseases is expected to drive the demand for regenerative medicine for cartilage market over the forecast period.
- Rising geriatric population is also anticipated to boost the demand for regenerative therapies as this population is more susceptible to joint injuries and other cartilage-related diseases.
- Technological advancements in regenerative medicine are likely to propel the growth of this market over the forecast period.
- Growing awareness about benefits of regenerative therapies is projected to fuel market growth during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Regenerative Medicine for Cartilage Market Research Report
By Type
Cell-based, Non-cell-based
By Application
Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Ribrous Cartilage Repair and Regeneration.
By Companies
B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Regenerative Medicine for Cartilage Market Report Segments:
The global Regenerative Medicine for Cartilage market is segmented on the basis of:
Types
Cell-based, Non-cell-based
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hyaline Cartilage Repair and Regeneration, Elastic Cartilage Repair and Regeneration, Ribrous Cartilage Repair and Regeneration.
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun Melsungen AG
- Zimmer Biomet Holdings Inc.
- Vericel Corporation
- Stryker Corporation
- Smith & Nephew plc
- Arthrex Inc.
- CONMED Corporation
- Collagen Solutions PLC
- BioTissue Technologies
- CellGenix
Highlights of The Regenerative Medicine for Cartilage Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell-based
- Non-cell-based
- By Application:
- Hyaline Cartilage Repair and Regeneration
- Elastic Cartilage Repair and Regeneration
- Ribrous Cartilage Repair and Regeneration.
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Regenerative Medicine for Cartilage Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Regenerative medicine is a field of medical science that uses cells, tissues, and organs from other animals or humans to repair or replace damaged tissue. In the case of cartilage regeneration, this may involve using cells taken from the patient's own skin or fat to create new cartilage.
Some of the major players in the regenerative medicine for cartilage market are B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Vericel Corporation, Stryker Corporation, Smith & Nephew plc, Arthrex Inc., CONMED Corporation, Collagen Solutions PLC, BioTissue Technologies, CellGenix.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Regenerative Medicine for Cartilage Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Regenerative Medicine for Cartilage Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Regenerative Medicine for Cartilage Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Regenerative Medicine for Cartilage Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Regenerative Medicine for Cartilage Market Size & Forecast, 2018-2028
4.5.1 Regenerative Medicine for Cartilage Market Size and Y-o-Y Growth
4.5.2 Regenerative Medicine for Cartilage Market Absolute $ Opportunity
Chapter 5 Global Regenerative Medicine for Cartilage Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Regenerative Medicine for Cartilage Market Size Forecast by Type
5.2.1 Cell-based
5.2.2 Non-cell-based
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Regenerative Medicine for Cartilage Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Regenerative Medicine for Cartilage Market Size Forecast by Applications
6.2.1 Hyaline Cartilage Repair and Regeneration
6.2.2 Elastic Cartilage Repair and Regeneration
6.2.3 Ribrous Cartilage Repair and Regeneration.
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Regenerative Medicine for Cartilage Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Regenerative Medicine for Cartilage Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Regenerative Medicine for Cartilage Analysis and Forecast
9.1 Introduction
9.2 North America Regenerative Medicine for Cartilage Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Regenerative Medicine for Cartilage Market Size Forecast by Type
9.6.1 Cell-based
9.6.2 Non-cell-based
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Regenerative Medicine for Cartilage Market Size Forecast by Applications
9.10.1 Hyaline Cartilage Repair and Regeneration
9.10.2 Elastic Cartilage Repair and Regeneration
9.10.3 Ribrous Cartilage Repair and Regeneration.
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Regenerative Medicine for Cartilage Analysis and Forecast
10.1 Introduction
10.2 Europe Regenerative Medicine for Cartilage Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Regenerative Medicine for Cartilage Market Size Forecast by Type
10.6.1 Cell-based
10.6.2 Non-cell-based
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Regenerative Medicine for Cartilage Market Size Forecast by Applications
10.10.1 Hyaline Cartilage Repair and Regeneration
10.10.2 Elastic Cartilage Repair and Regeneration
10.10.3 Ribrous Cartilage Repair and Regeneration.
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Regenerative Medicine for Cartilage Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Regenerative Medicine for Cartilage Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Regenerative Medicine for Cartilage Market Size Forecast by Type
11.6.1 Cell-based
11.6.2 Non-cell-based
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Regenerative Medicine for Cartilage Market Size Forecast by Applications
11.10.1 Hyaline Cartilage Repair and Regeneration
11.10.2 Elastic Cartilage Repair and Regeneration
11.10.3 Ribrous Cartilage Repair and Regeneration.
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Regenerative Medicine for Cartilage Analysis and Forecast
12.1 Introduction
12.2 Latin America Regenerative Medicine for Cartilage Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Regenerative Medicine for Cartilage Market Size Forecast by Type
12.6.1 Cell-based
12.6.2 Non-cell-based
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Regenerative Medicine for Cartilage Market Size Forecast by Applications
12.10.1 Hyaline Cartilage Repair and Regeneration
12.10.2 Elastic Cartilage Repair and Regeneration
12.10.3 Ribrous Cartilage Repair and Regeneration.
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Regenerative Medicine for Cartilage Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Regenerative Medicine for Cartilage Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Regenerative Medicine for Cartilage Market Size Forecast by Type
13.6.1 Cell-based
13.6.2 Non-cell-based
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Regenerative Medicine for Cartilage Market Size Forecast by Applications
13.10.1 Hyaline Cartilage Repair and Regeneration
13.10.2 Elastic Cartilage Repair and Regeneration
13.10.3 Ribrous Cartilage Repair and Regeneration.
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Regenerative Medicine for Cartilage Market: Competitive Dashboard
14.2 Global Regenerative Medicine for Cartilage Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 B. Braun Melsungen AG
14.3.2 Zimmer Biomet Holdings Inc.
14.3.3 Vericel Corporation
14.3.4 Stryker Corporation
14.3.5 Smith & Nephew plc
14.3.6 Arthrex Inc.
14.3.7 CONMED Corporation
14.3.8 Collagen Solutions PLC
14.3.9 BioTissue Technologies
14.3.10 CellGenix
